Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

Clinical trial NCT06631287 · RECRUITING

Trial details

NCT number

NCT06631287

Sponsor

Wes Ely

Status

RECRUITING

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2024-10-21

Primary completion

2026-11-01

Enrollment

550

View on ClinicalTrials.gov